Clinical Trial Update: Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update examining the effect of prolonged glucagon administration (72 hours) on energy expenditure in healthy obese individuals; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING